(Q34507541)

2 August 2017

title

Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection (English)

1 reference

2 August 2017

main subject

hepatocellular carcinoma

1 reference

Khan KN

1

1 reference

2 August 2017

Yatsuhashi H

2

1 reference

2 August 2017

Yamasaki K

3

1 reference

2 August 2017

Yamasaki M

4

1 reference

2 August 2017

Inoue O

5

1 reference

2 August 2017

Koga M

6

1 reference

2 August 2017

Yano M

7

1 reference

2 August 2017

publication date

1 February 2000

1 reference

2 August 2017

published in

Journal of Hepatology

1 reference

2 August 2017

volume

32

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

269-278

1 reference

Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Postoperative Recurrence of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Second hepatic resection for recurrent hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Second hepatoma developing 13 years after resection of first tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

α-fetoprotein: Reevaluation in hepatology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Expression of a multidrug resistance gene in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Overexpression of P-glycoprotein in adenomatous hyperplasia of human liver with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980072-0

7 January 2021

10.1016/S0168-8278(00)80072-0

Identifiers

DOI

1 reference

2 August 2017

1 reference